Skip to main content
OpenTrials
Completed

NCT Number: NCT02819011

OHI--Randomized Control Trial to Evaluate Efficacy, Acceptability, and Perception of Benefit of an Innovative Custom AFO

The investigators propose a randomized control trial to evaluate long term effects and effectiveness of Moore Balance Brace (MBB) ankle foot orthoses (AFO) in reducing risk of falling in older adults.

Primary Endpoints • Characterize the impact of MBB AFO on balance, gait, risk of falling, frailty status, and adverse events

Secondary Endpoints • Characterize the Impact of MBB AFO on spontaneous daily physical activities • Characterize the feasibility of the MBB AFO device on patient adherence, acceptability, user-friendliness, and perception of benefit for daily usage

Completed

Looking for future studies?

Notify Me

Key information

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • Age 65 or older
  • High concerns or high risk of fall
  • Ambulatory

Exclusion criteria

  • Presence of an active wound infection on either of the foot and ankle
  • Use of medication or a medical condition that may have unstable (fluctuate over time) or temporary (less than one month) impact on gait and balance
  • Acute fractures on the foot
  • Participant of an interventional study within the last 30 days
  • Non-ambulatory or unable to stand without help or walk a distance of at least 1.8 m (~six feet) without assistance
  • Major foot amputation
  • Unable or unwilling to participate in all procedures

Treatment and study plan

MBB AFO

Device

Subjects will be provided with a pair of New Balance 813 shoes plus a custom made MBB AFO

Control

Other

Subjects will be provided with a pair of New Balance 813 shoes

Primary outcomes

  1. Hip Sway Change From Baseline to 6 Months

    Time frame: baseline to 6 months

    Hip sway (motion of hip joints in three dimensions) measured by wearable sensors while wearing their own shoes compared to the orthopedic shoes and compared to orthopedic shoes plus Ankle-Foot Orthosis (AFO)

  2. Ankle Sway Change From Baseline to 6 Months

    Time frame: baseline to 6 months

    Ankle sway (motion of ankle joint in three dimensions) measured by wearable inertial sensors while wearing their own shoes compared to the orthopedic shoes and compared to orthopedic shoes plus Ankle-Foot Orthosis (AFO)

  3. Center of Mass (COM) Sway Change Baseline to 6 Months

    Time frame: baseline to 6 months

    Center of Mass (COM) sway measured by wearable inertial sensors while wearing their own shoes compared to the orthopedic shoes and compared to orthopedic shoes plus Ankle-Foot Orthosis (AFO)

Secondary outcomes

  1. Adherence (Hours Per Day to Wear Ankle-Foot Orthosis (AFO))

    Time frame: 6 months

    The adherence of participants to the prescribed Ankle-Foot Orthosis (AFO) plus walking shoes was quantified using the response to a self-reported question ("How many hours per day did you wear the prescribed footwear?").

  2. Fall Incidents

    Time frame: Baseline, 12 months

    Fall incidents during the study

  3. Concern for Falling Change Form Baseline to 6 Months

    Time frame: Baseline, 6 months

    Concern for falling is quantified by Falls Efficacy Scale - International (FES-I) questionnaire. Scores range from minimum 16 (no concern about falling) to maximum 64 (severe concern about falling). Higher score indicate worse performance.

  4. Physical Activity Level

    Time frame: baseline to 6 months

    Physical activity level for 24 hours while wearing their own shoes compared to the walking shoes and compared to walking shoes plus Ankle-Foot Orthosis (AFO). To quantify physical activity, number of taken steps per day was monitored using a pendant wearable sensor called, PAMSys (Biosensics, MA, USA).

  5. Number of Participants With Adverse Events

    Time frame: assessed at 1, 3, 6, and 12 months, month 12 reported

    Number of participants with adverse events reported during the study. Adverse events was inquired at 1 months, 3 months, 6 months, 12 months after the baseline, and summed at 12 months. If the participant has at least one adverse event reported in any assessed time frame, the participant will be categorized as the participant with adverse event.

  6. Percentage of Participants Who Found the Device Useful and Easy to Use

    Time frame: 6 months

    The participants perceived usefulness of ease of use of wearing Moore Balance Brace (MBB) Ankle-Foot Orthosis (AFO) based on questionnaires of A technology acceptance model (TAM). Perceived usefulness was assessed using two questions (i.e., "I feel more stable when standing," and "I feel more stable when walking"). Perceived ease of use was assessed using two questions (i.e., "Was easy to take on and off," and "Was comfortable to wear"). The Likert scale (6-point scale from 0-5) was used to quantify how much they disagreed with each statement, including "strongly disagree," "disagree," "somewhat disagree," "somewhat agree," "agree," and "strongly agree," respectively. In this paper, responses were only categorized as positive (3-5 points) or negative (0-2 points) attitudes towards the use of AFO plus walking shoes.

  7. Stride Velocity

    Time frame: baseline, 6 months

    stride velocity measured in single-task walking with normal speed

  8. Stride Time

    Time frame: baseline, 6 months

    stride time measured in single task walking with normal speed

  9. Stride Length

    Time frame: baseline, 6 months

    stride length measured in single-task walking with normal speed

Sponsors and collaborators

Lead sponsor

Bijan Najafi, PhD

Other

Collaborators

  • Orthotic Holdings, Inc.

Registry information

Important dates

Study start
2016
Primary completion
2018
Study completion
2019
First posted
Jun 30, 2016
Registry last updated
Feb 27, 2020

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.